Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 November 2022 | Story Gerda-Marié van Rooyen
Antjie Krog at UFS
The award-winning writer, Antjie Krog, will be the keynote speaker at the International Hybrid Conference from 24 to 26 November 2022. This conference is a joint venture of the University of the Free State (UFS) Centre for Gender and Africa Studies and the War Museum.

The award-winning writer, Antjie Krog, will be the keynote speaker later this week at an International Hybrid Conference titled, The Unsung Heroines and Youth of South Africa: Violent Histories and Experiences of South African Women and Children during Wars, Conflicts and Pandemics. This conference – a joint project of the Centre for Gender and Africa Studies at the University of the Free State (UFS) and the War Museum – starts on Thursday 24 November and will be hosted at the War Museum in Bloemfontein and broadcast online. The three-day conference overlaps with the global 16 Days of Activism Against Gender-Based Violence and aims to assemble historians, academics, and other scholars researching the violent histories of not only women and children in the South African War but in other wars, conflicts, and pandemics as well.

Prof Krog, an Extraordinary Professor in the Faculty of Arts at the University of the Western Cape, poet, and author of Country of my Skull (among other books), is an alumna of the UFS, where she completed a BA degree with Afrikaans, Philosophy, and English. She will deliver her keynote address, Survival, Complicity, and Race: (Im)possibilities of Narrating and Interpreting Rape in Havenga Affidavits, on the first day of the conference.

Prof Heidi Hudson, Dean of the Faculty of the Humanities at the UFS, will deliver her keynote address on Friday (25 November 2022). Prof Hudson is considered a specialist in feminist security studies. Her keynote address is titled Disciplinary and other stories: From women’s peace movements to the Women, Peace and Security ecosystem.

Several historians, academics, and scholars will either present their research or attend the conference. The conference aims to gather various stakeholders who are researching the violent histories of not only the women and children in the South African War, but other wars, conflicts, and pandemics in South African history dating from precolonial times to the World Wars, Apartheid, to the present. Each of the eight sessions over the first two days will conclude with time set aside for discussion.

The conference programme includes a visit to the art exhibition Unsung Heroes at the Oliewenhuis Art Museum on Friday after the last session. On Saturday, conference attendees can look forward to a tour of Bloemfontein. Click here for more information or send an email to vicky@anglo-boer.co.za.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept